![K. Min](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
K.
Chris Min is a former Senior Medical Director-Neurology at Bluerock Therapeutics, Inc. and a former VP, Head-Medical & Clinical Development at Enterin, Inc. In 2023, he served as the Chief Medical Officer at Longeveron, Inc. Dr. Min holds an undergraduate degree from Harvard University and doctorate degrees from The Rockefeller University and Weill Cornell Medical College.
Anciens postes connus de K. Min
Sociétés | Poste | Fin |
---|---|---|
LONGEVERON INC. | Directeur Général | 01/03/2023 |
Enterin, Inc.
![]() Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | Directeur Technique/Scientifique/R&D | 01/04/2021 |
Bluerock Therapeutics, Inc. | Corporate Officer/Principal | - |
Formation de K. Min
Weill Cornell Medical College | Doctorate Degree |
The Rockefeller University | Doctorate Degree |
Harvard University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
LONGEVERON INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Enterin, Inc.
![]() Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | Health Technology |
Bluerock Therapeutics, Inc. |